Show simple item record

dc.contributor.authorNg Kee Kwong, Koy Chong
dc.contributor.authorHarbham, Pratap K.
dc.contributor.authorSelvaraj, Bhuvaneish T.
dc.contributor.authorGregory, Jenna
dc.contributor.authorPal, Suvankar
dc.contributor.authorHardingham, Giles E.
dc.contributor.authorChandran, Siddharthan
dc.contributor.authorMehta, Arpan R.
dc.date.accessioned2022-07-06T11:27:01Z
dc.date.available2022-07-06T11:27:01Z
dc.date.issued2021-03-18
dc.identifier.citationNg Kee Kwong , K C , Harbham , P K , Selvaraj , B T , Gregory , J , Pal , S , Hardingham , G E , Chandran , S & Mehta , A R 2021 , ' 40 Years of CSF Toxicity Studies in ALS : What Have We Learnt About ALS Pathophysiology? ' , Frontiers in Molecular Neuroscience , vol. 14 , 647895 . https://doi.org/10.3389/fnmol.2021.647895en
dc.identifier.issn1662-5099
dc.identifier.otherPURE: 217891535
dc.identifier.otherPURE UUID: 32a76731-08a4-4b9c-9d81-43d368658f1a
dc.identifier.otherORCID: /0000-0003-3337-4079/work/112144115
dc.identifier.otherScopus: 85103494336
dc.identifier.urihttps://hdl.handle.net/2164/18803
dc.descriptionAM is a Lady Edith Wolfson Clinical Fellow and is jointly funded by the Medical Research Council (MRC) and the Motor Neurone Disease Association (MR/R001162/1). He also acknowledges support from the Rowling Scholars scheme, administered by the Anne Rowling Regenerative Neurology Clinic (ARRNC), University of Edinburgh, and a seedcorn grant from The Chief Scientist Office and the RS Macdonald Charitable Trust via the Scottish Neurological Research Fund, administered by the University of St Andrews. The Hardingham and Chandran laboratories are supported by the Euan MacDonald Centre for Motor Neurone Disease Research, and the UK Dementia Research Institute (DRI), which receives its funding from UK DRI Ltd., funded by the MRC, Alzheimer’s Society and Alzheimer’s Research UK.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofFrontiers in Molecular Neuroscienceen
dc.rightsCopyright © 2021 Ng Kee Kwong, Harbham, Selvaraj, Gregory, Pal, Hardingham, Chandran and Mehta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. https://creativecommons.org/licenses/by/4.0/en
dc.subjectamyotrophic lateral sclerosisen
dc.subject, cerebrospinal fluiden
dc.subjectmotor neuron diseaseen
dc.subjectneurodegenerationen
dc.subjectpathophysiologyen
dc.subjecttoxicityen
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/R001162/1en
dc.subjectAlzheimers Research UKen
dc.subject.lccRC0321en
dc.title40 Years of CSF Toxicity Studies in ALS : What Have We Learnt About ALS Pathophysiology?en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.University of Aberdeenen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3389/fnmol.2021.647895
dc.identifier.urlhttp://dx.doi.org/10.3389/fnmol.2021.647895en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record